WELLINGTON MANAGEMENT GROUP LLP

Position in TNGX — Tango Therapeutics, Inc.

CIK 902219 Boston, MA

Position in TNGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,049,644

+$3,977,672 QoQ

Shares Held

289,180

+23.7% QoQ

Ownership

0.200%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 70.58129884501002.ToString("F0")% None 29.418701154989975.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. TNGX ranks #79 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,049,644	289,180	+23.7%	Shares	Defined	2026-05-15
2025-12-31	$2,071,972	233,857	-7.7%	Shares	Defined	2026-02-17
2025-09-30	$2,127,618	253,288	+83.2%	Shares	Defined	2025-11-14
2024-12-31	$427,182	138,247	-3.5%	Shares	Defined	2025-02-12
2024-09-30	$1,102,693	143,207	-4.4%	Shares	Defined	2024-11-14
2024-06-30	$1,285,085	149,777	+6.2%	Shares	Defined	2024-08-14
2024-03-31	$1,119,499	140,995	-17.2%	Shares	Defined	2024-05-15
2023-12-31	$1,685,256	170,228	+110.8%	Shares	Defined	2024-02-12
2023-09-30	$909,211	80,747	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.